Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech News Today.
Press releases published on October 26, 2025
KFSHRC Advances Neurological Care with AI Powered Brain Implant
RIYADH, SAUDI ARABIA, October 26, 2025 /EINPresswire.com/ -- At King Faisal Specialist Hospital and Research Centre (KFSHRC), the frontier of neurology has begun to think for itself. In June 2025, surgeons implanted the Middle East’s first AI powered …
By.Storytellers Podcast Launches First-Ever Human + Multi-AI Dialogue Series
By.Storytellers Podcast Launches First-Ever Human + Multi-AI Dialogue Series ChatGPT, Claude, Gemini, Grok, and Meta. No prompts. No edits. Just dialogue. LOS ANGELES, CA, UNITED STATES, October 26, 2025 /EINPresswire.com/ -- By.Storytellers Podcast …
Unicorn Longevity Startup 600and1 Launches Ambitious Path to Decode and Bioengineer the Biology of Aging
Longevity Triple Doctor, Berenika Maciejewicz, leads the company’s cross-disciplinary team applying computational biology and bioengineering to extend lifespan. LOS ANGELES, CA, UNITED STATES, October 26, 2025 /EINPresswire.com/ -- 600and1, a pioneering …
Addressing Stigma: Mark Savaya Calls for Science-First Dialogue on Cannabis
TROY, MI, UNITED STATES, October 26, 2025 /EINPresswire.com/ -- Mark Savaya continues to encourage a fact-based public dialogue about cannabis, urging a shift away from outdated stigma and toward science-driven understanding. His advocacy aligns with a …
Edward Lillion Releases The Old Lords — A Supernatural Thriller Where Power, Faith, and Darkness Collide
A gripping debut that unearths ancient evils and the eternal struggle between redemption and damnation. OMAHA, NE, UNITED STATES, October 26, 2025 /EINPresswire.com/ -- Emerging author Edward Lillion announces the release of his debut novel, The Old …
Best Grounding Mat for Neuropathy recommended by TMIS
The Best Grounding Wellness Mat for Neuropathy Pain recommended by Dr. Hayden Ross at TMIS LA, CA, UNITED STATES, October 26, 2025 /EINPresswire.com/ -- The Best Grounding Wellness Mat for Neuropathy recommended by Dr. Hayden Ross at TMIS is "the most …
Ovation Fertility presents IVF insights at 2025 ASRM Scientific Congress & Expo
Studies highlight the use of artificial intelligence in embryo selection and miscarriage rates following frozen embryo transfer. SAN ANTONIO, TX, UNITED STATES, October 24, 2025 /EINPresswire.com/ -- Ovation Fertility’s research team will present two …
SXTC-DYADICA Global Brand Consulting Launches AI-Brand 5.0: Redefining the Future of Brand Building with AI Innovation
SXTC-DYADICA Global Brand Consulting Launches AI-Brand 5.0: Redefining the Future of Brand Building with AI (Artificial Intelligence) Brand Innovation ST. LOUIS, MO, UNITED STATES, October 26, 2025 /EINPresswire.com/ -- For over 30 years, SXTC-DYADICA …
Health Canada Grants Authorization for “LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease
TOKYO and CAMBRIDGE, Mass., Oct. 26, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) …
Vivani Medical, Inc. Announces Pricing of Common Stock Offering
ALAMEDA, Calif., Oct. 26, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, today announced the pricing of a best …
POET Technologies Announces Pricing of US$150 Million Oversubscribed Registered Direct Offering of Common Shares
The offering is being fully subscribed by two new fundamental investment managers Company’s pro-forma cash position expected to be in excess of US$300 million following closing TORONTO, Oct. 26, 2025 (GLOBE NEWSWIRE) -- POET Technologies Inc. (NASDAQ: …
Cygnus promeut un ingénieur chevronné à la tête des études économiques
TORONTO et PERTH, Australie, 26 oct. 2025 (GLOBE NEWSWIRE) -- Cygnus Metals Limited (ASX: CY5; TSXV: CYG; OTCQB: CYGGF) (« Cygnus » ou la « Société ») a le plaisir d'annoncer que Nick Kwong, chef de l'exploitation, sera promu en tant que président et chef …
Cygnus promotes highly experienced engineer to lead economic studies
TORONTO and PERTH, Australia, Oct. 26, 2025 (GLOBE NEWSWIRE) -- Cygnus Metals Limited (ASX: CY5; TSXV: CYG; OTCQB: CYGGF) (“Cygnus” or the “Company”) is pleased to announce that Chief Operating Officer “COO”) Nick Kwong will be promoted to President/Chief …
MapLight Therapeutics Announces Pricing of Initial Public Offering
SAN FRANCISCO and BOSTON, Oct. 26, 2025 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous system disorders, today announced the …
New Global Coalition Launches to Address the Hidden Threat of RSV in Adults
VIENNA, Austria, Oct. 26, 2025 (GLOBE NEWSWIRE) -- A new global coalition, the RSV Alliance, has been launched to raise awareness about the risks of respiratory syncytial virus (RSV) infections, with a focus on aging populations and individuals with …
New Data at American College of Gastroenterology Annual Meeting Show TissueCypher® Provides Actionable Risk Insights that Influence Clinical Management and Prompt Risk-Aligned Intervention in Barrett’s Esophagus
FRIENDSWOOD, Texas, Oct. 26, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data demonstrating that its TissueCypher® Barrett’s Esophagus …
Fate Therapeutics Presents New Clinical Data at ACR Convergence 2025 Demonstrating Immune Remodeling and Durable Responses in Patients with Systemic Lupus Erythematosus Treated with FT819 Off-the-Shelf CAR T-Cell Therapy
As of a September 25, 2025 data cut-off-date, 10 patients with treatment-refractory, moderate-to-severe Systemic Lupus Erythematosus (SLE) were treated with a single dose of FT819 with less-intensive or no conditioning chemotherapy Favorable safety profile …